Table 3: Checklists for monitoring the efficacy and safety of TRT in men with LOH and functional hypogonadism.
Section and Topic |
Checklist item |
Location where item is reported |
Project overview |
|
|
|
Title |
|
|
Protocol summary
|
|
|
Investigators/collaborators |
|
Introduction |
|
|
|
Rationale: describe the rationale for the LOH or FH study in the context of existing knowledge |
|
|
Objective & Hypotheses: Provide an explicit of the objectives & hypotheses on the study on LOH or FH |
|
|
Justification for the study |
|
Method/Procedure |
|
|
Design |
How the study design will meet the objectives and address hypotheses |
|
|
Study time line |
|
|
Protocol review request |
|
Study Population |
Case definition for LOH and FH |
|
|
Eligibility criteria: Should include inclusion and exclusion criteria for both participants and control for the study |
|
|
|
|
|
Sample size, sampling and statistical power |
|
|
Enrolment for the study |
|
Interventions or variables |
Study instruments including questionnaires, laboratory instruments and analytic test |
|
|
Intervention or treatment to be given to LOH of FH, at what interval and duration? |
|
|
Outcomes: Should include major adverse cardiovascular events as part of the primary outcome measures |
|
Data handling and Analysis |
Data collection |
|
|
Data entry, editing and management including storage |
|
|
Quality control and assurance |
|
|
Bias in data collection, measurement and analysis |
|
|
Limitation of study |
|
Adverse Events or Unexpected Findings |
Identify, managing and reporting of adverse events to interventions or placebo used in the study |
|
|
Emergency care available |
|
Notification, Reporting & Dissemination of Results |
Notify participants of their individual results and study findings |
|
|
Disseminate results on LOH and FH to the public |
|
References |
|
|
Appendix Material |
Data collection form and other relevant documents |
|
|
Tables and figures |
|